Equities research analysts at Oppenheimer started coverage on shares of Olema Pharmaceuticals ( NASDAQ:OLMA – Get Free Report ) in a research note issued to investors on Thursday, FlyOnTheWall reports. The brokerage set an 'outperform' rating on the stock. Several other equities research analysts have also commented on OLMA. Lifesci Capital reiterated an 'outperform' rating on shares of Olema Pharmaceuticals in a research note on Wednesday, April 26th. Capital One Financial raised their price target on shares of Olema Pharmaceuticals from $16.

https://www.dailypolitical.com/2023/07/20/olema-pharmaceuticals-nasdaqolma-coverage-initiated-by-analysts-at-oppenheimer.html

#dailypolitical